Lamivudine and Broken bone - a phase IV clinical study of FDA data

Summary:

Broken bone is reported as a side effect among people who take Lamivudine (lamivudine; zidovudine; nevirapine), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Hepsera, and have Acquired immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Broken bone when taking Lamivudine. It is created by eHealthMe based on reports of 17,197 people who have side effects when taking Lamivudine from the FDA, and is updated regularly.

What is Lamivudine?

Lamivudine has active ingredients of lamivudine; zidovudine; nevirapine. It is often used in hiv infection. eHealthMe is studying from 17,242 Lamivudine users. Check the latest studies of Lamivudine.

What is Broken bone?

Broken bone is found to be associated with 1,301 drugs and 1,494 conditions by eHealthMe. Check the latest studies of Broken bone.

On Aug, 11, 2026

17,197 people reported to have side effects when taking Lamivudine.
Among them, 14 people (0.08%) have Broken bone.

Among these 14 people:

How long have people been on Lamivudine when they have Broken bone? *

What is the gender of people who have Broken bone when taking Lamivudine? *

female: 14.29 %
male: 85.71 %

What is the age of people who have Broken bone when taking Lamivudine? *

What are other drugs people take besides Lamivudine? *

Hepsera: 7 people, 50.00%
Zidovudine: 3 people, 21.43%
Viread: 1 person, 7.14%
Tenofovir Disoproxil Fumarate: 1 person, 7.14%
Ritonavir: 1 person, 7.14%
Morphine Sulfate: 1 person, 7.14%
Diclofenac: 1 person, 7.14%
Colace: 1 person, 7.14%
Atazanavir Sulfate: 1 person, 7.14%
Atazanavir: 1 person, 7.14%

What are other side effects people have besides Broken bone? *

Osteomalacia (softening of the bones due to a lack of vitamin d): 8 people, 57.14%
Renal Tubular Disorder (disease of kidney tubules): 8 people, 57.14%
Blood Alkaline Phosphatase Increased: 7 people, 50.00%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 7 people, 50.00%
Bone Disorder: 7 people, 50.00%
Joint Pain: 7 people, 50.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 7 people, 50.00%
Drug Resistance (reduction in effectiveness of a drug): 7 people, 50.00%
Growth Retardation (delayed growth): 7 people, 50.00%
Back Pain: 7 people, 50.00%

What are the existing conditions these people have? *

Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 3 people, 21.43%
Pain: 1 person, 7.14%
Osteoporosis (bones weak and more likely to break): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lamivudine and have Broken bone?

- Check whether Broken bone is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamivudine:

Lamivudine (17,242 reports)

Broken bone treatments and more:

Broken bone (35,552 reports)

How severe was Broken bone and when was it recovered:

Broken bone in Lamivudine

Expand to all the drugs that have ingredients of lamivudine; zidovudine; nevirapine:

Broken bone and drugs with ingredients of lamivudine; zidovudine; nevirapine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamivudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Broken bone:

Broken bone (1,301 drugs)

Browse all the conditions that are associated with Broken bone:

Broken bone (1,494 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lamivudine; zidovudine; nevirapine (the active ingredients of Lamivudine) and Lamivudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.